Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Highwoods Properties

Altria is undervalued with a 9% dividend yield and a history of strong total returns. Despite concerns about declining cigarette volumes, MO's strong margins and growth in reduced risk products make it an attractive investment. Highwoods Properties is a quality REIT with office properties in attractive growth markets and offers an 8% dividend yield.

Two +8% Yielders The Market Is Sleeping On

Devon Energy

Pfizer

High dividend stocks for your September 2023 watch list.

3 High Dividend Stocks To Watch Before September 2023

Management attributes Altria's lagging financial results to the lingering effects of inflation. Despite consumer spending habits, Altria is increasing its quarterly dividend and remains committed to further share buybacks.

Bull Market or Not, There Is 1 Glaring Reason to Own Altria Stock

Broadcom

Alphabet

Microsoft

Palo Alto Networks

Paychex

Cash cows bring in loads of free cash flow that help them sustain dividends and buybacks – and generate long-term value for investors.

Best Cash Cows to Buy

Altria (MO) benefits from its smoke-free alternatives and pricing strength amid cost inflation and low cigarette volumes.

Altria's (MO) Pricing & Smoke-Free Strength Aid Amid Hurdles

AT&T

Truist Financial

Verizon

Walgreens

Investors love dividend stocks. They not only provide dependable income, but they also give investors a great opportunity for solid total return.

The 5 Highest-Yielding S&P 500 Stocks With Big Upside Potential and 7% or Higher Dividends

Altria Group is the king of the Dividend Kings, with 54 consecutive years of dividend increases and a dividend yield of 8.98%. MO's future dividend plan aims for mid-single-digit annual increases, making it an attractive investment for income-focused investors. MO's valuation appears undervalued compared to other Dividend Kings, presenting an opportunity for capital appreciation and a high yield.

Altria: This Dividend King Increased Its Dividend 4.3% And Yields 8.98%

Amcor Plc

Community Trust Bancorp

Enbridge

Enterprise Products Partners

National Retail Properties

Realty Income Corp

Philip Morris

September is historically the worst month for stocks. That's due to a surprising reason that no longer applies. This September, the effects of the strongest Fed hiking cycle in 42 years are likely to start showing up in the data. Overvalued stocks could suffer significant declines, but 5%-plus yielding aristocrats are likely to hold up much better.

The Best 5%-Plus Yielding Dividend Aristocrats For August

Altria Group has achieved its 54th consecutive year of dividend increase, demonstrating its commitment to increasing income for shareholders. The company's dividend payout ratios are still in line with its previously stated policy of paying out 80% of earnings, indicating that it can continue paying its high dividend. Altria's operating discipline, pricing power, and consistent dividend growth make it an attractive investment option for income-focused investors.

Altria: 54 And Counting

Warren Buffett has been a persistent buyer of profitable companies with a wide moat. We select companies that generously distribute earnings via growing dividends. Our two top choices boast up to 9% yields and have a legacy of decades-long dividend growth.

Buffett Says Build Passive Income, 2 Dividends For Your Retirement

Altria is the owner of Marlboro cigarettes and other tobacco products. The company has counteracted cigarette volume declines through price increases.

This Dividend Giant Is Now Yielding 8.8%: Should You Buy Shares?

Vertex Pharmaceuticals

Walmart

The stock market recovered nicely from last year's debacle. The Nasdaq Composite Index in particular went from a 34% loss in 2022 to a 29% gain so far this year.

Got $600? Here are 3 No-Brainer Stocks You Absolutely Must Buy

Altria Group Inc. MO, +0.07% said Thursday its board has approved a 4.3% hike in its quarterly dividend to 98 cents a share. The new dividend will be payable Oct. 10 to shareholders of record as of Sept.

Altria raises quarterly dividend by 4.3% to 98 cents a share

RICHMOND, Va.--(BUSINESS WIRE)-- #ALTRIA--ALTRIA INCREASES QUARTERLY DIVIDEND BY 4.3% TO $0.98 PER SHARE.

Altria Increases Quarterly Dividend by 4.3% to $0.98 Per Share

Dividend investors are willing to sacrifice growth in exchange for income collecting periodic dividend payments. This makes dividend stocks a stable, heavily owned and long-term investment.

5 Best High-Yield Dividend Stocks for Any Economic Climate

Adobe

Amgen

Procter & Gamble

Altria is able to stand up to tough environments because consumers are slow to give up their bad habits. Procter & Gamble is the powerhouse name behind some of the world's best-known brands.

4 Surefire Stocks to Buy in the Next Bear Market

KeyCorp

About three-fourths of the S&P 500 pay a dividend. According to S&P Dow Jones Indices, dividends have contributed approximately 32% of total S&P return since 1926.

5 High-Yielding S&P Stocks: Is It The Right Time To Buy?

Juul is awaiting a decision from U.S. regulators on whether its products can remain on the market.

Juul to cut 30% of its workforce in bid to cut costs and boost profitability

The cuts will reduce operating expenses by $225 million, the Journal reported.

E-cigarette maker Juul slashing 30% of workforce in bid to cut costs

Juul Labs is planning to lay off 30% of its workforce as it looks to cut costs, the Wall Street Journal reported on Wednesday.

Juul to lay off 30% of workforce in bid to cut costs - WSJ

Arbor Realty Trust

Ares Commercial Real Estate

Apollo Commercial Real Estate Finance

BrightSpire Capital

British American Tobacco

FS Credit Opportunities Corp

JPMorgan Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

Kraft Heinz

Modiv

AG Mortgage Investment Trust

ETRACS Monthly Pay 1.5X Leveraged Mortgage REIT ETN

Triplepoint Venture Growth BDC

V.F.

Prior to July 31, my readers mentioned 39 equities in their comments on my articles. Some bad news investments (Rogues) mixed with (mostly) Favorites. Thus, these are ReFa/Ro. Ten analyst-target-estimated TOP-NET-GAIN Re/Fa/Ro: MO, ACRE, PFE, O, KHC, MDV, VFC, BRSP, BTI, and MITT, averaged 48.7% net gains from reader data collected 8/18/23. Ten analyst-target-augured July top-price upside reader faves and rogues (ReFa/Ro) were: MDV, BIIB, KHC, PARA, VFC, DIS, BRSP, BTI and MITT boasting a 47.71% average target price upside estimate.

Readers Post 20 July Dividend Buys

Altria bought NJOY in June after the tobacco conglomerate exited its stake in Juul.

Altria Group sues Juul over e-vapor patent infringement

Altria Group said on Tuesday its subsidiary, NJOY, has filed a complaint against Juul Labs with the U.S. International Trade Commission, seeking a ban on the import and sale of certain Juul e-vapor products.

Altria seeks import ban on certain Juul e-vapor products

RICHMOND, Va.--(BUSINESS WIRE)--Altria Seeks Importation Ban of JUUL E-Vapor Products; Files Patent Infringement Actions Against JUUL Labs.

Altria Seeks Importation Ban of JUUL E-Vapor Products; Files Patent Infringement Actions Against JUUL Labs

Sysco

Tootsie Roll Industries

Dividend Kings are tried and true investments with a long history of sustained dividend payments and distribution increases. The kind of track records that help investors sleep soundly at night, but these stocks are not always easy to buy.

News for Altria Stock (MO)